Wellington, NZ, 15 January 2020: Volpara Health Technologies (“Volpara” or ”the Company”; ASX: VHT), a SaaS medical technology company whose AI imaging algorithms assist the early detection of breast cancer,...
Practice Management Tools Provide Access to Workflow and Image Quality Analytics to Help Improve Mammographic Quality and Maximize Resource Utilization.
Randomized Controlled Trial Reduces Interval Breast Cancers in Women Assessed as Extremely Dense by Volpara®Density™ Software
Clinical Decision-Support Tools Provide Radiologists Easy Access to Key Insights to Offer Women a Personalized Breast Care Plan
Wellington, NZ, October 29, 2019: Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Advisory Board.
Volpara Signs Distribution Agreement to Sell Transpara™, Screenpoint Medical’s AI Solution for Breast Cancer Detection
Wellington, NZ, July 23, 2019 – Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products to breast imaging clinics...
Breast Imaging Analytics Software Helps Breast Care Team Deliver Personalized Health with High-Quality Images
Companies Committed to Deliver Technologies Enabling Personalized Breast Care
Wellington, NZ, May 20, 2019 – Research has demonstrated that the use of Volpara Solutions’ Volpara®Density™ software in combination with the Tyrer-Cuzick Breast Cancer Risk Evaluation Tool improves breast cancer...
MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States